These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7138588)

  • 21. Dependence of the antagonism at human platelet 5-HT2 receptors by ketanserin on the reaction pH.
    De Clerck F; Xhonneux B; Tollenaere JP; Janssen PA
    Thromb Res; 1985 Dec; 40(5):581-96. PubMed ID: 2935970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketanserin alters [3H]serotonin uptake and release in rat hypothalamus.
    Offord SJ; Warwick RO
    Eur J Pharmacol; 1984 Sep; 104(3-4):379-82. PubMed ID: 6499929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet hypersensitivity to serotonin after prolonged ketanserin intake?
    Arnout J; Van Russelt M; Deckmyn H; Vermylen J; Fiocchi R; Lijnen P; Amery A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S20-2. PubMed ID: 2412049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular pharmacology of ketanserin.
    Van Nueten JM; Vanhoutte PM
    Bibl Cardiol; 1984; (38):222-33. PubMed ID: 6099724
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of serotonin on rat ileocolonic transit and fluid transfer in vivo: possible mechanisms of action.
    Oosterbosch L; von der Ohe M; Valdovinos MA; Kost LJ; Phillips SF; Camilleri M
    Gut; 1993 Jun; 34(6):794-8. PubMed ID: 8100206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of serotonergic agents on neuronal nicotinic acetylcholine receptors.
    García-Colunga J; Miledi R
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2919-23. PubMed ID: 7708749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
    Glusa E; Markwardt F
    Biomed Biochim Acta; 1984; 43(2):215-20. PubMed ID: 6732757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade.
    Cohen RA
    J Pharmacol Exp Ther; 1986 May; 237(2):548-52. PubMed ID: 2939235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of urapidil on 5-hydroxytryptamine induced platelet aggregation and on 14C-5-hydroxytryptamine uptake in platelets.
    Storck J; Ochs JG; Kirsten R
    Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):303-8. PubMed ID: 2387654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Demonstration of S2-receptor binding sites on cat blood platelets using [3H]ketanserin.
    Leysen JE; Gommeren W; De Clerck F
    Eur J Pharmacol; 1983 Mar; 88(1):125-30. PubMed ID: 6852103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Action of immobilized neuraminidase on the accumulation of 5-hydroxytryptamine by human platelets.
    Masters VM; Webster J; Cook GM
    Biochem Pharmacol; 1980 Dec; 29(23):3189-201. PubMed ID: 7447956
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies into the dual effects of serotonergic pharmacological agents on female sexual behaviour in the rat: preliminary evidence that endogenous 5HT is stimulatory.
    Hunter AJ; Hole DR; Wilson CA
    Pharmacol Biochem Behav; 1985 Jan; 22(1):5-13. PubMed ID: 3156384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age, platelet serotonin kinetics and 5HT2-receptor blockade in essential hypertension.
    Amstein R; Fetkovska N; Bühler FR
    J Hum Hypertens; 1990 Aug; 4(4):441-4. PubMed ID: 2258891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries.
    Cohen RA; Shepherd JT; Vanhoutte PM
    Am J Physiol; 1983 Dec; 245(6):H1077-80. PubMed ID: 6660308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of protriptyline and clomipramine in vitro on the uptake of 5-hydroxytryptamine and dopamine in human platelet-rich plasma.
    Trenchard A; Turner P; Pare CM; Hills M
    Psychopharmacologia; 1975 Jul; 43(1):89-93. PubMed ID: 1161997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of methysergide on platelets incubated with reserpine.
    Cumings JN; Hilton BP
    Br J Pharmacol; 1971 Aug; 42(4):611-9. PubMed ID: 5116036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid intracellular release of calcium in human platelets by stimulation of 5-HT2-receptors.
    Erne P; Pletscher A
    Br J Pharmacol; 1985 Feb; 84(2):545-9. PubMed ID: 3156650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ketanserin on the hyperreactivity of platelets to 5-hydroxytryptamine in patients with cardiovascular diseases.
    De Cree J; Leempoels J; Demoen B; Roels V; Verhaegen H
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S26-8. PubMed ID: 2412051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral 5-HT2-like receptors. Can they be classified with the available antagonists?
    Leff P; Martin GR
    Br J Pharmacol; 1986 Jul; 88(3):585-93. PubMed ID: 2943354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketanserin does not prevent ACTH-induced hypertension in sheep.
    Nelson MA; Coghlan JP; Denton DA; Whitworth JA; Scoggins BA
    Clin Exp Pharmacol Physiol; 1985; 12(2):155-9. PubMed ID: 2988838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.